Oak Ridge researchers are converting nuclear waste into components for targeted alpha therapy, a cancer treatment that ...

Dr. Ma discussed key findings that have been shared so far this year on the topic of evolving treatment strategies for ...

Iovance Biotherapeutics’ Amtagvi study data shows 49 per cent response rate for commercialisation: San Carlos, California Thursday, July 17, 2025, 12:00 Hrs [IST] Iovance Biothe ...

A specially engineered antibody that can accurately deliver RNA treatments into hard-to-reach and hard-to-treat tumors ...

Lifezoom, a pioneer of red light therapy in the USA, is excited to expand with the new industry-leading Veyra Series, red ...

Novartis is launching a $10 billion share buyback to be completed by year-end 2027 as new drug launches accelerate. | ...

Discover a study that reveals a targetable CA125+ cell state in rare bladder cancer subtypes using single-cell RNA sequencing.

Clarity Pharmaceuticals (ASX: CU6) ('Clarity' or 'Company'), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...

A radio presenter and Herefordshire teacher was left partially sighted after developing a rare and aggressive cancer.

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

Want a bespoke baby? Check the beauty, brains, or brawn boxes on the embryo order form. Genetic tinkering is no longer science fiction—it’s a market without legal guidelines or societal buy-in. But ...

Pimple patches have helped make acne ‘acceptable’ and added the fun into functionality, but now the format is expanding to ...